The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

The Inteleos Foundation, an international nonprofit organization driving access to medical imaging, has announced the addition of two esteemed members to the Board of Directors for 2025, further ...

Previously, Matt served as Director of Corporate Affairs at Pfizer Rare Disease, where he advanced communications, patient advocacy, and policy initiatives. Before transitioning to healthcare ...

Haematologist Dr Sue Pavord was one of the jab’s biggest supporters, but she knew something was wrong when she saw the ...

We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.

A new biotech spun out of Pfizer is to develop four drugs for rare and serious diseases. SpringWorks is the brainchild of Lara Sullivan, a former Pfizer R&D strategy executive who gained Pfizer's ...

The internet is full of false claims. Columnist Sam Kirton shares why fact-checking is important, particularly for the rare disease world.

Pfizer said last November that it was spinning ... however and recently started a phase 3 trial in dermatomyositis, a rare disease that causes skin rashes and muscle inflammation, can lead to ...

Edgewise Therapeutics , Inc., a biotechnology company specializing in pharmaceutical preparations, announced the promotion of ...